Profile: Oragenics, Inc. is a biopharmaceutical company. We develop replacement therapy, DPOLT™ synthetic chemistry platform and LPT3-04™ weight loss agent. Our replacement therapy is a single, painless topical treatment that has the potential to offer life-long protection from most tooth decay. Our DPOLT™ Differentially Protected Orthogonal Lantionine Technology (DPOLT™) is a solid phase peptide synthesis platform technology that has broad application for the manufacture of a number of commercially important bioactive peptides.